Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: A cross-sectional study

Abstract Background: Studies have documented that older children and adolescents act as a reservoir of Bordetella pertussis infection for young infants who have not yet completed their primary immunization schedule. Asymptomatic pertussis infection has been reported during outbreaks. This cross-sectional study aimed to investigate whether B. pertussis and Bordetella parapertussis can colonize the nasopharynx of healthy school children, using culture and pooled real-time PCR with targets for insertion sequences IS481 and IS1001. Methods: Nasopharyngeal (NP) swabs were taken from 629 asymptomatic school children aged 7 to 15 y in 4 counties of China during the period July–September 2011. The number of subjects included in each county ranged from 153 to 165. The 4 counties selected are located in the north, south, east, and southwest regions of China. NP swabs were inoculated onto Regan–Lowe agar for isolation of suspected Bordetella organisms. Pooled real-time PCRs were used to detect B. pertussis and B. parapertussis based on the IS481 and IS1001 targets separately. Results: Of the 629 subjects, 2 (0.3%) and 30 (4.8%) were confirmed to be culture-positive and PCR-positive, respectively, for B. pertussis, and 1 (0.2%) and 13 (2.1%) were confirmed to be culture-positive and PCR-positive, respectively, for B. parapertussis. All culture-positive samples were also PCR-positive. Furthermore, positive B. pertussis and B. parapertussis samples were found in all counties. Conclusions: Our results indicate that asymptomatic B. pertussis infections are common in school children in China, and asymptomatic B. parapertussis infections are more prevalent than previously documented.

[1]  R. Rodby,et al.  Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety data , 2014, Expert review of clinical pharmacology.

[2]  C. Kenyon,et al.  Waning Immunity to Pertussis Following 5 Doses of DTaP , 2013, Pediatrics.

[3]  N. Xu,et al.  The seroepidemiology of Immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study , 2012, BMC Infectious Diseases.

[4]  M. Witt,et al.  Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  H. Hallander,et al.  Is adolescent pertussis vaccination preferable to natural booster infections? , 2011, Expert review of clinical pharmacology.

[6]  F. Mooi,et al.  Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis , 2010, PloS one.

[7]  M. Riffelmann,et al.  Performance of Commercial Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Bordetella pertussis , 2010, Journal of Clinical Microbiology.

[8]  K. Krogfelt,et al.  Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. , 2010, Journal of medical microbiology.

[9]  M. Littmann,et al.  Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[10]  E. Bingen,et al.  Real-Time PCR Measurement of Persistence of Bordetella pertussis DNA in Nasopharyngeal Secretions during Antibiotic Treatment of Young Children with Pertussis , 2008, Journal of Clinical Microbiology.

[11]  M. Nissen,et al.  Bordetella pertussis PCR positivity, following onset of illness in children under 5 years of age. , 2007, Communicable diseases intelligence quarterly report.

[12]  J. Caro,et al.  Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. , 2007, Vaccine.

[13]  A. Edwards,et al.  Perinatal infections, prematurity and brain injury , 2006, Current opinion in pediatrics.

[14]  D. Greenberg Pertussis in Adolescents: Increasing Incidence Brings Attention to the Need for Booster Immunization of Adolescents , 2005, The Pediatric infectious disease journal.

[15]  J. Mertsola,et al.  Defining Pertussis Epidemiology: Clinical, Microbiologic and Serologic Perspectives , 2005, The Pediatric infectious disease journal.

[16]  J. Caro,et al.  Potential Strategies to Reduce the Burden of Pertussis , 2005, The Pediatric infectious disease journal.

[17]  J. Cherry The Epidemiology of Pertussis: A Comparison of the Epidemiology of the Disease Pertussis With the Epidemiology of Bordetella pertussis Infection , 2005, Pediatrics.

[18]  P. McIntyre,et al.  High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine. , 2004, Vaccine.

[19]  D. Cohen,et al.  An outbreak of pertussis among young Israeli soldiers , 2003, Epidemiology and Infection.

[20]  K. Nishioka,et al.  High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. , 2003, Journal of virological methods.

[21]  S. Lauwers,et al.  Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  U. Reischl,et al.  Real-Time LightCycler PCR for Detection and Discrimination of Bordetella pertussis and Bordetella parapertussis , 2002, Journal of Clinical Microbiology.

[23]  I. Srugo,et al.  Pertussis infection in fully vaccinated children in day-care centers, Israel. , 2000, Emerging infectious diseases.

[24]  F. Müller,et al.  Laboratory diagnosis of pertussis: state of the art in 1997 , 1997, Journal of clinical microbiology.

[25]  M K Viljanen,et al.  Outcomes of Bordetella pertussis infection in different age groups of an immunized population. , 1994, The Journal of infectious diseases.

[26]  H. Davies,et al.  Clinical and microbiologic features of children presenting with pertussis to a Canadian pediatric hospital during an eleven-year period. , 1994, The Pediatric infectious disease journal.

[27]  J. Cherry,et al.  Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. , 1994, The Pediatric infectious disease journal.

[28]  J. Mertsola,et al.  Sensitive and specific polymerase chain reaction assays for detection of Bordetella pertussis in nasopharyngeal specimens. , 1994, The Journal of pediatrics.

[29]  J. Cherry,et al.  Serious pertussis overlooked in infants , 1992, European Journal of Pediatrics.

[30]  S. Long,et al.  Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. , 1990, The Journal of infectious diseases.

[31]  M. Bassett,et al.  Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries. , 1988, Journal of clinical pathology.

[32]  JamesW. Bass IS THERE A CARRIER STATE IN PERTUSSIS? , 1987, The Lancet.

[33]  C. M. Steel,et al.  Letter: Rosetting tests. , 1974, Lancet.

[34]  C. Linnemann,et al.  The carrier state in pertussis. , 1968, American journal of epidemiology.

[35]  K. Edwards,et al.  Adolescent and adult pertussis: disease burden and prevention. , 2006, Current opinion in pediatrics.

[36]  K. Alestig,et al.  The carrier state in pertussis. , 1986, Scandinavian journal of infectious diseases.